Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius Sells 22 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 22 shares of the company’s stock in a transaction on Wednesday, May 14th. The stock was sold at an average price of $563.00, for a total value of $12,386.00. Following the transaction, the senior vice president now directly owns 2,025 shares in the company, valued at $1,140,075. This represents a 1.07% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Mark Brosius also recently made the following trade(s):

• On Monday, May 12th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The stock was sold at an average price of $551.97, for a total value of $12,143.34.
• On Friday, March 7th, Mark Brosius sold 489 shares of Intuitive Surgical stock. The stock was sold at an average price of $533.18, for a total value of $260,725.02.
• On Wednesday, March 5th, Mark Brosius sold 492 shares of Intuitive Surgical stock. The stock was sold at an average price of $554.17, for a total value of $272,651.64.
• On Monday, March 3rd, Mark Brosius sold 492 shares of Intuitive Surgical stock. The shares were sold at an average price of $573.78, for a total value of $282,299.76.

Intuitive Surgical Trading Down 1.0%

NASDAQ ISRG opened at $560.28 on Friday. The business’s 50-day moving average price is $503.82 and its 200 day moving average price is $536.13. Intuitive Surgical, Inc. has a twelve month low of $393.98 and a twelve month high of $616.00. The company has a market capitalization of $200.81 billion, a PE ratio of 87.41, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the prior year, the business posted $1.50 earnings per share. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analysts Set New Price Targets

Several analysts have weighed in on ISRG shares. CICC Research started coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price on the stock. Raymond James upped their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. UBS Group upped their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Citigroup upped their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Finally, JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $598.95.

Hedge Funds Weigh In On Intuitive Surgical

Several large investors have recently added to or reduced their stakes in ISRG. Brookstone Capital Management lifted its position in Intuitive Surgical by 25.4% during the fourth quarter. Brookstone Capital Management now owns 18,102 shares of the medical equipment provider’s stock worth $9,448,000 after buying an additional 3,663 shares during the period. Capital Investment Advisors LLC lifted its position in Intuitive Surgical by 15.6% during the fourth quarter. Capital Investment Advisors LLC now owns 899 shares of the medical equipment provider’s stock worth $469,000 after buying an additional 121 shares during the period. Fragasso Financial Advisors Inc raised its holdings in shares of Intuitive Surgical by 3.0% in the 4th quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock worth $359,000 after purchasing an additional 20 shares during the period. Cooper Financial Group raised its holdings in shares of Intuitive Surgical by 23.4% in the 4th quarter. Cooper Financial Group now owns 1,059 shares of the medical equipment provider’s stock worth $553,000 after purchasing an additional 201 shares during the period. Finally, Claro Advisors LLC raised its holdings in shares of Intuitive Surgical by 3.1% in the 4th quarter. Claro Advisors LLC now owns 1,250 shares of the medical equipment provider’s stock worth $652,000 after purchasing an additional 37 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.